Syneron Medical (Syneron Medical) Days Sales Outstanding : 76.71 (As of Mar. 2017)

View and export this data going back to 2004. Start your Free Trial

What is Syneron Medical Days Sales Outstanding?

Syneron Medical's average Accounts Receivable for the three months ended in Mar. 2017 was $56.2 Mil. Syneron Medical's Revenue for the three months ended in Mar. 2017 was $66.9 Mil. Hence, Syneron Medical's Days Sales Outstanding for the three months ended in Mar. 2017 was 76.71.

The historical rank and industry rank for Syneron Medical's Days Sales Outstanding or its related term are showing as below:

ELOS's Days Sales Outstanding is not ranked ^*
in the Medical Devices & Instruments industry.
Industry Median: 64.635
* Ranked among companies with meaningful Days Sales Outstanding only.

Syneron Medical's Days Sales Outstanding increased from Mar. 2016 (74.50) to Mar. 2017 (76.71).

Syneron Medical Days Sales Outstanding Historical Data

The historical data trend for Syneron Medical's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Syneron Medical Days Sales Outstanding Chart

Syneron Medical Annual Data

Trend

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Days Sales Outstanding

Get a 7-Day Free Trial

64.61

74.06

78.59

71.81

67.81

Syneron Medical Quarterly Data
	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17
Days Sales Outstanding	Get a 7-Day Free Trial															74.50	69.15	68.57	60.54	76.71

Competitive Comparison of Syneron Medical's Days Sales Outstanding

For the Medical Devices subindustry, Syneron Medical's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Syneron Medical's Days Sales Outstanding Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Syneron Medical's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Syneron Medical's Days Sales Outstanding falls into.

Syneron Medical Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Syneron Medical's Days Sales Outstanding for the fiscal year that ended in Dec. 2016 is calculated as

	Days Sales Outstanding (A: Dec. 2016 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2015 )	+	Accounts Receivable (A: Dec. 2016 ))	/	count )	/	Revenue (A: Dec. 2016 )	*	Days in Period
=	( (53.423	+	57.337)	/	2 )	/	298.102	*	365
=	55.38					/	298.102	*	365
=	67.81

Syneron Medical's Days Sales Outstanding for the quarter that ended in Mar. 2017 is calculated as:

	Days Sales Outstanding (Q: Mar. 2017 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2016 )	+	Accounts Receivable (A: Mar. 2017 ))	/	count )	/	Revenue (A: Mar. 2017 )	*	Days in Period
=	( (57.337	+	55.105)	/	2 )	/	66.88	*	365 / 4
=	56.221					/	66.88	*	365 / 4
=	76.71

Syneron Medical (NAS:ELOS) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Syneron Medical Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Syneron Medical's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Syneron Medical (Syneron Medical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Syneron Medical Ltd (NAS:ELOS) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.syneron.com

Syneron Medical Ltd., was incorporated in the State of Israel in July 2000. The Company completed its initial public offering of ordinary shares in August 2004. It designs, develops and markets aesthetic medical products based on its various technologies including its proprietary Electro-Optical Synergy, or ELOS, technology, which uses the synergy between electrical energy, including radiofrequency or RF energy, and optical energy to provide effective, safe and affordable aesthetic medical treatments. The Company's products, which it sells mainly to physicians and other practitioners, target non-invasive aesthetic medical procedures, including hair removal, wrinkle reduction, rejuvenation of the skin's appearance through the treatment of superficial benign vascular and pigmented lesions, acne treatment, treatment of leg veins, treatment for the temporary reduction in the appearance of cellulite and thigh circumference, ablation and resurfacing of the skin and laser-assisted lipolysis and topical skin brightening products.

Executives

North Tide Capital, Llc	10 percent owner	500 BOYLSTON STREET, SUITE 1860, BOSTON MA 02116
Laughlin Conan	director, 10 percent owner	C/O NORTH TIDE CAPITAL, LLC, 500 BOYLSTON STREET, SUITE 1860, BOSTON MA 02116
North Tide Capital Master, Lp	10 percent owner	C/O NORTH TIDE CAPITAL, LLC, 500 BOYLSTON STREET, SUITE 1860, BOSTON MA 02116

Syneron Medical (Syneron Medical) Headlines

From GuruFocus

Why Is Seth Klarman Loading Up on Syneron Medical?

By matsandalex matsandalex • 08-29-2011

Seth Klarman Buys First American Corp., Universal Compression Holdings, School Specialty Inc., Sells Courtside Acquisition Corp, Healthsouth Corp.

By gurufocus • 08-13-2007

Top Seth Klarman Holding, ELOS Rockets Up 20%

By matsandalex matsandalex • 02-17-2011

Seth Klarman More Than Doubles Holdings in Syneron Medical

By teddycx teddycx • 07-12-2011